Treatment of patients with severe von willebrand disease undergoing elective surgery by administration of recombinant VWF

• 收藏
• 分享

专利权人:

Baxalta Incorporated;Baxalta GmbH

发明人:

CHAPMAN, Miranda,EWENSTEIN, Bruce,PLODER, Bettina

申请号：

AU2018298232

公开号：

AU2018298232A1

申请日:

2018.07.09

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

The present invention relates to method for pretreating a subject with severe von Willebrand disease prior to a surgical procedure comprising administering to the subject a dose ranging from about 20 IU/kg to about 60 IU/kg rVWF between about 12 hours and about 24 hours prior to the surgical procedure, and wherein Factor VIII is not administered with the rVWF prior to the surgical procedure.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/